# Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

> **NCT01043523** · — · COMPLETED · sponsor: **Bayer** · enrollment: 52 (actual)

## Conditions studied

- Liver Neoplasms
- Adenoma
- Carcinoma
- Liver Abscess

## Interventions

- **DRUG:** Gadoxetic Acid Disodium (Eovist, BAY86-4873)

## Key facts

- **NCT ID:** NCT01043523
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043523, "Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01043523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*